Perdagangan Qiagen NV - QIA CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.150 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.017913% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.004309% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | EUR | ||||||||
Margin | 20% | ||||||||
Bursa efek | Germany | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Qiagen NV ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Key Stats
Prev. Close* | 42.54 |
Open* | 42.4 |
1-Year Change* | -4.38% |
Day's Range* | 42.35 - 43.04 |
52 wk Range | 40.38-51.18 |
Average Volume (10 days) | 725.45K |
Average Volume (3 months) | 13.39M |
Market Cap | 10.51B |
P/E Ratio | 25.10 |
Shares Outstanding | 227.72M |
Revenue | 2.14B |
EPS | 1.84 |
Dividend (Yield %) | N/A |
Beta | 0.39 |
Next Earnings Date | Apr 24, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 42.390 | 0.200 | 0.47% | 42.190 | 43.050 | 42.190 |
Mar 23, 2023 | 42.540 | 0.290 | 0.69% | 42.250 | 42.560 | 42.010 |
Mar 22, 2023 | 42.760 | 0.100 | 0.23% | 42.660 | 43.060 | 42.660 |
Mar 21, 2023 | 42.680 | 0.090 | 0.21% | 42.590 | 42.850 | 42.390 |
Mar 20, 2023 | 42.630 | -0.420 | -0.98% | 43.050 | 43.330 | 42.550 |
Mar 17, 2023 | 43.180 | 0.080 | 0.19% | 43.100 | 44.000 | 43.080 |
Mar 16, 2023 | 43.720 | -0.030 | -0.07% | 43.750 | 43.890 | 43.180 |
Mar 15, 2023 | 43.190 | 0.250 | 0.58% | 42.940 | 43.440 | 42.420 |
Mar 14, 2023 | 42.960 | -0.400 | -0.92% | 43.360 | 43.580 | 42.180 |
Mar 13, 2023 | 43.240 | 0.060 | 0.14% | 43.180 | 43.680 | 43.180 |
Mar 10, 2023 | 43.500 | 0.280 | 0.65% | 43.220 | 43.930 | 43.220 |
Mar 9, 2023 | 43.710 | 0.490 | 1.13% | 43.220 | 43.800 | 43.210 |
Mar 8, 2023 | 43.620 | 0.260 | 0.60% | 43.360 | 43.710 | 43.280 |
Mar 7, 2023 | 43.790 | -0.060 | -0.14% | 43.850 | 44.260 | 43.700 |
Mar 6, 2023 | 43.570 | 0.240 | 0.55% | 43.330 | 43.790 | 43.210 |
Mar 3, 2023 | 43.420 | 0.230 | 0.53% | 43.190 | 43.500 | 43.070 |
Mar 2, 2023 | 42.890 | 0.320 | 0.75% | 42.570 | 43.030 | 42.360 |
Mar 1, 2023 | 42.630 | -0.950 | -2.18% | 43.580 | 43.580 | 42.560 |
Feb 28, 2023 | 43.570 | -0.030 | -0.07% | 43.600 | 43.740 | 43.310 |
Feb 27, 2023 | 43.890 | -0.030 | -0.07% | 43.920 | 43.970 | 43.420 |
Qiagen NV Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Revenue | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Cost of Revenue, Total | 756.955 | 800.837 | 637.631 | 521.162 | 499.271 |
Gross Profit | 1384.56 | 1450.82 | 1232.71 | 1005.26 | 1002.58 |
Total Operating Expense | 1610.06 | 1621.57 | 1483.92 | 1547.76 | 1235.27 |
Selling/General/Admin. Expenses, Total | 603.945 | 584.468 | 525.362 | 505.268 | 508.146 |
Research & Development | 189.859 | 189.964 | 149.072 | 157.448 | 161.852 |
Depreciation / Amortization | 14.531 | 18.542 | 20.811 | 29.973 | 39.032 |
Unusual Expense (Income) | 44.768 | 27.762 | 151.039 | 333.91 | 26.966 |
Operating Income | 531.46 | 630.084 | 386.431 | -21.337 | 266.581 |
Interest Income (Expense), Net Non-Operating | -19.1 | -5.122 | -59.918 | -43.696 | -70.168 |
Other, Net | 0.241 | 0.871 | 112.959 | -12.743 | 29.324 |
Net Income Before Taxes | 512.601 | 625.833 | 439.472 | -77.776 | 225.737 |
Net Income After Taxes | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Minority Interest | 0 | ||||
Net Income Before Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Net Income | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Income Available to Common Excl. Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Income Available to Common Incl. Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Dilution Adjustment | 0 | ||||
Diluted Net Income | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Diluted Weighted Average Shares | 230.136 | 232.034 | 234.214 | 226.777 | 233.456 |
Diluted EPS Excluding Extraordinary Items | 1.83896 | 2.20915 | 1.53359 | -0.1828 | 0.81549 |
Diluted Normalized EPS | 1.99957 | 2.30715 | 2.00343 | 0.77427 | 0.9129 |
Total Extraordinary Items |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total revenue | 497.984 | 499.631 | 515.512 | 628.391 | 582.398 |
Revenue | 497.984 | 499.631 | 515.512 | 628.391 | 582.398 |
Cost of Revenue, Total | 180.46 | 178.58 | 184.494 | 213.421 | 208.574 |
Gross Profit | 317.524 | 321.051 | 331.018 | 414.97 | 373.824 |
Total Operating Expense | 393.411 | 401.972 | 393.355 | 421.32 | 409.257 |
Selling/General/Admin. Expenses, Total | 154.211 | 145.462 | 151.418 | 152.854 | 152.274 |
Research & Development | 44.719 | 48.868 | 49.896 | 46.376 | 42.113 |
Depreciation / Amortization | 5.969 | 2.846 | 2.799 | 2.917 | 3.345 |
Unusual Expense (Income) | 8.052 | 26.216 | 4.748 | 5.752 | 2.951 |
Operating Income | 104.573 | 97.659 | 122.157 | 207.071 | 173.141 |
Interest Income (Expense), Net Non-Operating | 1.387 | -2.452 | -6.521 | -11.414 | -7.275 |
Other, Net | -0.123 | 0.511 | -0.112 | -0.135 | -0.487 |
Net Income Before Taxes | 105.837 | 95.718 | 115.524 | 195.522 | 165.379 |
Net Income After Taxes | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Net Income Before Extra. Items | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Net Income | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Income Available to Common Excl. Extra. Items | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Income Available to Common Incl. Extra. Items | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Diluted Net Income | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Diluted Weighted Average Shares | 230.358 | 230.084 | 229.938 | 230.164 | 231.761 |
Diluted EPS Excluding Extraordinary Items | 0.38568 | 0.3581 | 0.42038 | 0.67479 | 0.55741 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Diluted Normalized EPS | 0.41502 | 0.45618 | 0.43766 | 0.69464 | 0.56736 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 2109.6 | 1624.41 | 1570.25 | 2155.06 | 1647.97 |
Cash and Short Term Investments | 1065.3 | 715.233 | 753.233 | 1393.69 | 657.714 |
Cash | 235.381 | 245.373 | 189.569 | 208.083 | 139.597 |
Short Term Investments | 184.785 | 117.249 | 563.664 | 1185.6 | 518.117 |
Total Receivables, Net | 469.663 | 486.605 | 484.608 | 422.091 | 761.617 |
Accounts Receivable - Trade, Net | 376.213 | 389.058 | 385.117 | 351.612 | 329.138 |
Total Inventory | 327.525 | 291.181 | 170.704 | 162.912 | 155.927 |
Prepaid Expenses | 60.629 | 61.159 | 45.409 | 48.25 | 41.775 |
Other Current Assets, Total | 186.484 | 70.227 | 116.294 | 128.122 | 30.94 |
Total Assets | 6146.95 | 5869.62 | 5235.62 | 5748.33 | 5038.52 |
Property/Plant/Equipment, Total - Net | 739.077 | 661.894 | 455.243 | 511.659 | 494.321 |
Property/Plant/Equipment, Total - Gross | 1371.49 | 1292.34 | 1154.37 | 1115.09 | 1058.91 |
Accumulated Depreciation, Total | -632.416 | -630.443 | -699.13 | -603.43 | -564.588 |
Goodwill, Net | 2350.76 | 2364.03 | 2140.5 | 2108.54 | 2012.9 |
Intangibles, Net | 627.436 | 726.194 | 632.434 | 475.043 | 499.318 |
Other Long Term Assets, Total | 294.676 | 488.995 | 356.488 | 437.434 | 328.7 |
Total Current Liabilities | 1517.47 | 572.175 | 951.345 | 972.189 | 324.792 |
Accounts Payable | 101.224 | 118.153 | 84.767 | 69.415 | 59.205 |
Accrued Expenses | 219.936 | 220.755 | 332.151 | 209.748 | 173.307 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 847.626 | 42.539 | 285.244 | 503.177 | 1.359 |
Other Current Liabilities, Total | 348.684 | 190.728 | 249.183 | 189.849 | 90.921 |
Total Liabilities | 3050.4 | 3071.78 | 2699.02 | 3113.36 | 2497.52 |
Total Long Term Debt | 1094.14 | 1880.21 | 1421.11 | 1671.09 | 1758.26 |
Long Term Debt | 1094.14 | 1880.21 | 1421.11 | 1671.09 | 1758.26 |
Deferred Income Tax | 37.591 | 39.216 | 23.442 | 63.411 | 76.727 |
Minority Interest | |||||
Other Liabilities, Total | 401.199 | 580.179 | 303.13 | 406.672 | 337.743 |
Total Equity | 3096.55 | 2797.84 | 2536.59 | 2634.97 | 2541 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1818.51 | 1834.17 | 1777.02 | 1742.19 | 1630.09 |
Retained Earnings (Accumulated Deficit) | 1791.74 | 1323.09 | 1178.46 | 1379.62 | 1247.94 |
Treasury Stock - Common | -189.73 | -118.301 | -111.966 | -178.903 | -118.987 |
Unrealized Gain (Loss) | 0 | -0.942 | |||
Other Equity, Total | -326.67 | -243.822 | -309.619 | -310.644 | -219.817 |
Total Liabilities & Shareholders’ Equity | 6146.95 | 5869.62 | 5235.62 | 5748.33 | 5038.52 |
Total Common Shares Outstanding | 227.074 | 227.985 | 227.752 | 225.509 | 226.557 |
Long Term Investments | 25.4 | 4.1 | 80.7 | 60.6 | 41.1 |
Note Receivable - Long Term | 14.2 | ||||
Cash & Equivalents | 645.135 | 352.611 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 2097.25 | 2109.6 | 2028.4 | 1802.19 | 1665.55 |
Cash and Short Term Investments | 1229.8 | 1065.3 | 957.318 | 898.021 | 791.732 |
Cash & Equivalents | 770.515 | 880.516 | 617.541 | 759.047 | 787.786 |
Short Term Investments | 459.285 | 184.785 | 339.777 | 138.974 | 3.946 |
Total Receivables, Net | 386.683 | 376.213 | 373.62 | 366.151 | 371.694 |
Accounts Receivable - Trade, Net | 386.683 | 376.213 | 372.22 | 366.151 | 371.694 |
Total Inventory | 321.621 | 327.525 | 335.691 | 341.041 | 316.28 |
Prepaid Expenses | 159.147 | 165.279 | 361.767 | 196.982 | 185.844 |
Total Assets | 6184.28 | 6146.95 | 6043.43 | 5907.48 | 5762.61 |
Property/Plant/Equipment, Total - Net | 638.225 | 739.077 | 612.114 | 599.991 | 563.917 |
Property/Plant/Equipment, Total - Gross | 1244.08 | 1270.6 | 1245.82 | 1245.04 | 1186.38 |
Accumulated Depreciation, Total | -605.858 | -632.416 | -633.706 | -645.05 | -622.464 |
Goodwill, Net | 2346.74 | 2350.76 | 2353.91 | 2332.7 | 2335.27 |
Intangibles, Net | 607.738 | 627.436 | 638.786 | 667.273 | 695.937 |
Long Term Investments | 26.6 | 25.4 | 19.5 | 21.5 | 17.1 |
Other Long Term Assets, Total | 467.728 | 294.676 | 390.72 | 483.821 | 484.836 |
Total Current Liabilities | 957.283 | 1517.47 | 1070.03 | 503.117 | 499.384 |
Accounts Payable | 87.012 | 101.224 | 94.265 | 103.004 | 103.471 |
Accrued Expenses | 335.279 | 568.62 | 571.229 | 325.813 | 335.713 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 468.792 | 847.626 | 371.637 | 0 | 0 |
Other Current Liabilities, Total | 66.2 | 32.9 | 74.3 | 60.2 | |
Total Liabilities | 2944.14 | 3050.4 | 3029.69 | 2929.6 | 2912.83 |
Total Long Term Debt | 1474.9 | 1094.14 | 1568.66 | 1939.71 | 1928.95 |
Long Term Debt | 1474.9 | 1094.14 | 1568.66 | 1939.71 | 1928.95 |
Deferred Income Tax | 36.921 | 37.591 | 22.102 | 22.824 | 10.146 |
Other Liabilities, Total | 475.038 | 401.199 | 368.9 | 463.951 | 474.353 |
Total Equity | 3240.14 | 3096.55 | 3013.74 | 2977.87 | 2849.78 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1830.59 | 1818.51 | 1811.54 | 1799.41 | 1789.81 |
Retained Earnings (Accumulated Deficit) | 1913.66 | 1791.74 | 1665.67 | 1537.48 | 1430.53 |
Treasury Stock - Common | -172.993 | -189.73 | -174.565 | -100.763 | -107.014 |
Other Equity, Total | -333.822 | -326.67 | -291.601 | -260.966 | -266.245 |
Total Liabilities & Shareholders’ Equity | 6184.28 | 6146.95 | 6043.43 | 5907.48 | 5762.61 |
Total Common Shares Outstanding | 227.452 | 227.074 | 227.336 | 228.638 | 228.407 |
Other Current Assets, Total | 175.284 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | 512.599 | 359.188 | -41.455 | 190.38 | 40.394 |
Cash From Operating Activities | 639.001 | 457.806 | 330.843 | 359.496 | 286.779 |
Cash From Operating Activities | 214.931 | 205.014 | 231.458 | 206.436 | 216.448 |
Deferred Taxes | -5.288 | -6.706 | -55.362 | -23.272 | 60.176 |
Non-Cash Items | 46.771 | -27.423 | 240.526 | 81.111 | 57.617 |
Cash Taxes Paid | 102.083 | 42.572 | 41.474 | 29.317 | 40.499 |
Cash Interest Paid | 21.588 | 25.351 | 29.721 | 25.902 | 20.252 |
Changes in Working Capital | -130.012 | -72.267 | -44.324 | -95.159 | -87.856 |
Cash From Investing Activities | -202.426 | -443.281 | -222.278 | -211.356 | -464.264 |
Capital Expenditures | -206.534 | -304.237 | -274.884 | -150.763 | -124.405 |
Other Investing Cash Flow Items, Total | 4.108 | -139.044 | 52.606 | -60.593 | -339.859 |
Cash From Financing Activities | -150.366 | -50.127 | -639.08 | 360.408 | 387.187 |
Financing Cash Flow Items | -16.953 | -23.451 | -61.279 | -8.019 | -8.587 |
Issuance (Retirement) of Stock, Net | -92.068 | 8.876 | 62.362 | -27.867 | -253.444 |
Issuance (Retirement) of Debt, Net | -41.345 | -35.552 | -640.163 | 396.294 | 649.218 |
Foreign Exchange Effects | -3.677 | 4.196 | 0.826 | -7.183 | 8.832 |
Net Change in Cash | 282.532 | -31.406 | -529.689 | 501.365 | 218.534 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 155.312 | 512.599 | 383.413 | 250.274 | 129.223 |
Cash From Operating Activities | 207.41 | 639.001 | 440.543 | 285.026 | 128.627 |
Cash From Operating Activities | 52.998 | 214.931 | 163.83 | 110.669 | 55.587 |
Deferred Taxes | 0.615 | -5.288 | -29.394 | -30.993 | -28.396 |
Non-Cash Items | 21.86 | 46.771 | 35.251 | 40.196 | 12.034 |
Changes in Working Capital | -23.375 | -130.012 | -112.557 | -85.12 | -39.821 |
Cash From Investing Activities | -306.252 | -202.426 | -297.717 | -78.682 | 105.975 |
Capital Expenditures | -38.415 | -206.534 | -152.531 | -101.254 | -54.959 |
Other Investing Cash Flow Items, Total | -267.837 | 4.108 | -145.186 | 22.572 | 160.934 |
Cash From Financing Activities | -10.658 | -150.366 | -119.397 | -43.478 | -40.852 |
Financing Cash Flow Items | -10.687 | -16.953 | -3.625 | -4.847 | -2.017 |
Issuance (Retirement) of Stock, Net | 0.029 | -92.068 | -74.427 | 2.714 | 2.51 |
Issuance (Retirement) of Debt, Net | 0 | -41.345 | -41.345 | -41.345 | -41.345 |
Foreign Exchange Effects | -0.501 | -3.677 | -3.872 | -1.803 | -3.948 |
Net Change in Cash | -110.001 | 282.532 | 19.557 | 161.063 | 189.802 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
MFS Investment Management | Investment Advisor/Hedge Fund | 8.6971 | 19804737 | 392074 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.6439 | 8297775 | 129513 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.5214 | 5741604 | 932553 | 2022-12-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.4157 | 5500907 | 100754 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9693 | 4484423 | 201234 | 2022-12-31 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 1.8894 | 4302433 | -955906 | 2022-12-31 | LOW |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8793 | 4279398 | 765282 | 2022-12-19 | LOW |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.625 | 3700311 | 215475 | 2022-12-31 | MED |
Capital World Investors | Investment Advisor | 1.6138 | 3674825 | 0 | 2022-12-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 1.3725 | 3125386 | 101378 | 2023-02-28 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.3706 | 3120999 | 0 | 2023-01-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.1858 | 2700209 | -568539 | 2022-12-31 | MED |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.141 | 2598279 | -510278 | 2022-12-31 | LOW |
Fidelity International | Investment Advisor | 0.9847 | 2242311 | 85153 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 0.9721 | 2213542 | -138096 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9392 | 2138763 | -104054 | 2022-12-31 | LOW |
BofA Global Research (US) | Research Firm | 0.9294 | 2116389 | -914109 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9046 | 2060006 | 265911 | 2022-12-31 | LOW |
Davidson Kempner Capital Management LP | Hedge Fund | 0.8948 | 2037709 | -61957 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.8507 | 1937191 | 116735 | 2022-12-31 | MED |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Biotechnology & Medical Research (NEC) |
Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com